Skip to main content
William Helton, MD, General Surgery, Seattle, WA, Virginia Mason Medical Center

WilliamScottHeltonMD

General Surgery Seattle, WA

Director Liver, Biliary and Pancreas Surgery Center of Excellence

Dr. Helton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Helton's full profile

Already have an account?

Summary

  • I am an academic general surgeon with fellowship training in liver, pancreas and biliary surgery. I am currently the director of The Liver, Biliary, and Pancreas Surgery Center of Excellence at Viriginia Mason Medical Center is Seattle Washington and Clinical Professor of Surgery at the University of Washington. I have published over 150 pear-reviewed publications and 25 text book chapters. I have been a leader in the field of HPB surgery in North America for the past 25 years and past President of the America's HPB Association. My clinical interests are in the management of primary liver cancer, pancreatitis, pancreatic cancer, and bile duct injury. I have been involved in the development of surgical instrumentation to improve the safety of performing liver resection as well as the ablation of liver tumors. My other surgical interests are in managing small bowel obstruction and complex hernia surgery.

Education & Training

  • University of Toronto
    University of TorontoFellowship in liver, pancreas surgery and transplantation, Liver, Pancreas and Bile duct surgery, 1990 - 1991
  • Brigham and Womens Hospital
    Brigham and Womens HospitalFellowship, Clinical Nutrition, 1988 - 1990
  • University of Washington
    University of WashingtonResidency, Surgery, 1981 - 1986
  • University of California, Irvine, School of Medicine
    University of California, Irvine, School of MedicineClass of 1981
  • University of California, Berkeley
    University of California, BerkeleyB.A., Psychology, 1973 - 1977

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1982 - 2024
  • FL State Medical License
    FL State Medical License 2019 - 2021
  • CT State Medical License
    CT State Medical License 2006 - 2011
  • IL State Medical License
    IL State Medical License 1998 - 2008
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • Joel Baker Teaching Award Virginia Mason Medical Center, Department of Surgery, 2020
  • President Seattle Surgical Society, 2020
  • America’s Top Doctors, Seattle Magazine, Castle Connally,, 2019-2020
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Does mesenteric venous imaging assessment accurately predict pathologic invasion in localized pancreatic ductal adenocarcinoma?  
    Clanton J, Oh S, Kaplan SJ, Johnson E, Ross A, Kozarek R, Alseidi A, Biehl T, Picozzi VJ, Helton WS, Coy D, Dorer R, Rocha FG, HPB (Oxford), 1/9/2018
  • Gemcitabine and Taxane Adjuvant Therapy with Chemoradiation in Resected Pancreatic Cancer: A Novel Strategy for Improved Survival?  
    Kanji ZS, Edwards AM, Mandelson MT, Sahar N, Lin BS, Badiozamani K, Song G, Alseidi A, Biehl TR, Kozarek RA, Helton WS, Picozzi VJ, Rocha FG, Ann Surg Oncol, 1/1/2018
  • Localized pancreatic cancer with positive peritoneal cytology as a sole manifestation of metastatic disease: a single-institution experience  
    Oh SY, Edwards A, Mandelson MT, Hahn H, Alseidi A, Biehl T, Kozarek RA, Rocha FG, Helton S, Picozzi VJ, Am J Surg, 1/1/2017
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Sarcopenia as a predictor for completion of extended neoadjuvant chemotherapy in patients with borderline resectable pancreatic adenocarcinoma (BRPA).
    K. Penn, J. B. Rose, W. S. Helton, 50th Annual Pancreas Club Meeting, Annual Wilske Research Symposium, San Diego, CA; Virginia Mason Medical Center, 1/20/2016
  • Pattern of CA19-9 response to neoadjuvant chemotherapy in locally advanced, borderline resectable pancreatic cancer predicts progression.
    Rose JB, Edwards AM, Alseidi AA, Biehl TR, Lin BS, Picozzi V, Rocha FG, Helton WS, 50th Annual Pancreas Club Meeting, San Diego, CA, 1/20/2016
  • Randomized, Open-Label Trial of Gemcitabine/Nab-Paclitaxel with or without FG-3019 as Neoadjuvant Chemotherapy in Locally Advanced, Unresectable Pancreatic Ductal Aden...
    Vincent J. Picozzi, MD; Flavio Rocha, MD; Scott Helton, MD; Kabir Mody, MD; Horacio Asbun, MD; Mike Pishvanian, MD; Patrick Jackson, MD; Tina Etheridge; Mairead Carney..., GI ASCO, 1/1/2016
  • Join now to see all

Lectures

  • Where Does Catheter Drainage Belong in MIS For Pancreatitis? 
    Seattle, WA - 1/12/2018
  • Chronic Pancreatitis - Medical, Surgical, Endoscopic & Pain Perspectives. 
    1/2/2018
  • Vascular Resection in Pancreatectomy. 
    Cancun, Mexico - 1/5/2017
  • Join now to see all

Other

  • Management of E3 Biliary Injury. 
    Deal S, Rocha F, Alseidi A, Biehl T, Helton WS, The Annual Meeting of AHPBA (Americas Hepato-Pancreato-Biliary Association)
    Miami, FL - 1/1/2017
  • Successful management of intrahepatic biliary rupture of echinococcal cyst without liver resection. 
    WS Helton, American College of Surgeons
    Chicago, IL - 1/1/2015
  • Pancreatic Head Resection and Pancreaticojejunostomy for Chronic Pancreatitis. 
    WS Helton, ACS Video Atlas Showcase - Pancreas Surgery Volume, American College of Surgeons
    San Francisco - 1/29/2014
  • Join now to see all

Press Mentions

  • Top Doctors 2021: Surgery
    Top Doctors 2021: SurgeryMay 13th, 2021

Professional Memberships

Hospital Affiliations